MedTrace Logo

Investigating the Effect of Dronabinol on Post-surgical Pain

NCT04099355 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL

Last updated 2023-11-13

No results posted yet for this study

Summary

This study is designed to investigate the effect of dronabinol on post operative pain in patients undergoing total knee replacement (for their own clinical care).

Conditions

  • Knee Replacement
  • Arthropathy of Knee

Interventions

DRUG

Dronabinol 5mg Cap

1 QAM and 2 QHS PO 14 days

DRUG

Non-active comparator

1 QAM and 2 QHS PO 14 days

Sponsors & Collaborators

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Diana Martinez, MD · NYSPI

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2027-08-30
Completion
2027-08-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04099355 on ClinicalTrials.gov